Securities ▲▼ | Shares | Value | |||||
|---|---|---|---|---|---|---|---|
Q2 2026 ▲▼ | Q3 2026 ▲▼ | Change ▲▼ | Q2 2026 ▲▼ | Q3 2026 ▲▼ | Weight (%) ▲▼ | Change ▲▼ | |
| Praxis Precision Medicines, Inc.(PRAX) | 88,781 | 76,600 | -12,181 | $29.72M | $22.31M | 21.33% | -$7.41M |
| Immix Biopharma, Inc.(IMMX) | 1,085,000 | 1,085,000 | 0 | $11.19M | $11.29M | 10.79% | +$103.1K |
| Protara Therapeutics, Inc.(TARA) | 2,844,652 | 2,844,652 | 0 | $10.87M | $8.68M | 8.29% | -$2.19M |
| Sutro Biopharma, Inc.(STRO) | 512,160 | 510,038 | -2,122 | $17.00M | $8.22M | 7.85% | -$8.79M |
| ABIVAX Société AnonymeADS(ABVX) | 65,630 | 65,630 | 0 | $8.75M | $6.50M | 6.21% | -$2.25M |
| MapLight Therapeutics, Inc.(MPLT) | 492,893 | 624,703 | +131,810 | $17.67M | $6.37M | 6.09% | -$11.30M |
| Anteris Technologies Global Corp.(AVR) | 700,000 | 700,000 | 0 | $6.89M | $5.44M | 5.20% | -$1.46M |
| Edesa Biotech, Inc.(EDSA) | 827,500 | 1,282,045 | +454,545 | $6.73M | $5.40M | 5.16% | -$1.33M |
| Avalo Therapeutics, Inc.(AVTX) | 324,452 | 324,452 | 0 | $6.00M | $4.97M | 4.75% | -$1.02M |
| Xencor, Inc.(XNCR) | 255,000 | 175,000 | -80,000 | $4.11M | $4.37M | 4.17% | +$260.8K |
| Evommune, Inc.(EVMN) | 451,255 | 456,255 | +5,000 | $6.00M | $3.77M | 3.60% | -$2.23M |
| Eupraxia Pharmaceuticals Inc.(EPRX) | 352,000 | 352,000 | 0 | $2.33M | $3.20M | 3.06% | +$876.5K |
| Heron Therapeutics, Inc.(HRTX) | 8,753,290 | 8,753,290 | 0 | $3.74M | $2.74M | 2.62% | -$991.7K |
| Edgewise Therapeutics, Inc.(EWTX) | 0 | 34,250 | +34,250 | $0 | $1.39M | 1.33% | +$1.39M |
| Rein Therapeutics Inc.(RNTX) | 1,700,000 | 1,700,000 | 0 | $1.77M | $1.37M | 1.31% | -$401.2K |
| Nasus Pharma Ltd.(NSRX) | 359,390 | 359,390 | 0 | $1.26M | $1.33M | 1.27% | +$68.3K |
| Q32 Bio Inc.(QTTB) | 0 | 120,000 | +120,000 | $0 | $992.4K | 0.95% | +$992.4K |
| InspireMD, Inc.(NSPR) | 148,138 | 924,680 | +776,542 | $103.7K | $617.5K | 0.59% | +$513.8K |
| Protagonist Therapeutics Inc | 3,700 | 3,700 | 0 | $453.5K | $521.3K | 0.50% | +$67.7K |
| Aardvark Therapeutics Inc | 0 | 85,868 | +85,868 | $0 | $452.5K | 0.43% | +$452.5K |
| Nurix Therapeutics, Inc.(NRIX) | 16,000 | 16,000 | 0 | $388.2K | $379.4K | 0.36% | -$8.8K |
| CytomX Therapeutics, Inc.(CTMX) | 120,000 | 120,000 | 0 | $450.0K | $326.4K | 0.31% | -$123.6K |
| Ovid Therapeutics Inc.(OVID) | 130,000 | 130,000 | 0 | $349.7K | $323.7K | 0.31% | -$26.0K |
| Mineralys Therapeutics, Inc.(MLYS) | 11,000 | 11,000 | 0 | $296.8K | $276.4K | 0.26% | -$20.4K |
| Replimune Group, Inc.(REPL) | 20,000 | 20,000 | 0 | $221.4K | $264.8K | 0.25% | +$43.4K |
| Precision BioSciences, Inc.(DTIL) | 40,000 | 40,000 | 0 | $314.4K | $250.4K | 0.24% | -$64.0K |
| Zai Lab LimitedADR(ZLAB) | 0 | 9,000 | +9,000 | $0 | $237.1K | 0.23% | +$237.1K |
| C4 Therapeutics, Inc.(CCCC) | 570,000 | 70,000 | -500,000 | $2.66M | $233.1K | 0.22% | -$2.43M |
| MacroGenics, Inc.(MGNX) | 60,000 | 60,000 | 0 | $277.2K | $231.6K | 0.22% | -$45.6K |
| Immunome, Inc.(IMNM) | 10,000 | 10,000 | 0 | $211.9K | $215.1K | 0.21% | +$3.2K |
| An2 Therapeutics Inc | 40,000 | 40,000 | 0 | $193.6K | $212.8K | 0.20% | +$19.2K |
| Viridian Therapeutics, Inc.(VRDN) | 10,000 | 10,000 | 0 | $183.7K | $205.9K | 0.20% | +$22.2K |
| Corbus Pharmaceuticals Holdings, Inc.(CRBP) | 26,000 | 30,000 | +4,000 | $243.9K | $204.6K | 0.20% | -$39.3K |
| Enanta Pharmaceuticals, Inc.(ENTA) | 0 | 15,000 | +15,000 | $0 | $197.7K | 0.19% | +$197.7K |
| Scynexis Inc | 40,000 | 40,000 | 0 | $162.8K | $197.6K | 0.19% | +$34.8K |
| Artiva Biotherapeutics, Inc.(ARTV) | 25,000 | 25,000 | 0 | $242.5K | $178.0K | 0.17% | -$64.5K |
| Rocket Pharmaceuticals, Inc.(RCKT) | 60,000 | 60,000 | 0 | $205.2K | $157.8K | 0.15% | -$47.4K |
| Lyell Immunopharma, Inc.(LYEL) | 105,000 | 15,000 | -90,000 | $1.48M | $146.8K | 0.14% | -$1.33M |
| Jade Biosciences Inc | 0 | 10,000 | +10,000 | $0 | $140.5K | 0.13% | +$140.5K |
| Neumora Therapeutics, Inc.(NMRA) | 230,000 | 230,000 | 0 | $391.0K | $137.1K | 0.13% | -$253.9K |
| Larimar Therapeutics, Inc.(LRMR) | 33,000 | 33,000 | 0 | $100.7K | $105.4K | 0.10% | +$4.8K |
| Kalaris Therapeutics, Inc.(KLRS) | 25,000 | 25,000 | 0 | $101.8K | $72.3K | 0.07% | -$29.5K |
| Adma Biologics Inc | 250,000 | 0 | -250,000 | $2.09M | $0 | — | -$2.09M |
| Context Therapeutics Inc.(CNTX) | 59,700 | 0 | -59,700 | $33.1K | $0 | — | -$33.1K |
| Gossamer Bio, Inc.(GOSS) | 70,000 | 0 | -70,000 | $11.5K | $0 | — | -$11.5K |
| Jasper Therapeutics, Inc.(JSPR) | 2,668,395 | 0 | -2,668,395 | $1.12M | $0 | — | -$1.12M |
| Karyopharm Therapeutics Inc.(KPTI) | 20,000 | 0 | -20,000 | $195.4K | $0 | — | -$195.4K |
| Profound Medical Corp.(PROF) | 170,278 | 0 | -170,278 | $1.13M | $0 | — | -$1.13M |
| Proqr Thrapeutics N VSHS EURO SHS EURO | 45,000 | 0 | -45,000 | $83.7K | $0 | — | -$83.7K |
| Quoin Pharmaceuticals, Ltd.ADS(QNRX) | 32,372 | 0 | -32,372 | $156.7K | $0 | — | -$156.7K |
| Rezolute, Inc.(RZLT) | 750,000 | 0 | -750,000 | $3.90M | $0 | — | -$3.90M |
| Syndax Pharmaceuticals, Inc.(SNDX) | 10,000 | 0 | -10,000 | $218.6K | $0 | — | -$218.6K |
| Tectonic Therapeutic, Inc.(TECX) | 6,000 | 0 | -6,000 | $206.3K | $0 | — | -$206.3K |
| Tenax Therapeutics, Inc.(TENX) | 549,985 | 0 | -549,985 | $8.00M | $0 | — | -$8.00M |
| Verrica Pharmaceuticals Inc.(VRCA) | 471,559 | 0 | -471,559 | $2.89M | $0 | — | -$2.89M |
| Xilio Therapeutics, Inc.(XLO) | 14,285 | 0 | -14,285 | $136.8K | $0 | — | -$136.8K |